JOIN OUR APAC 2016
19th October 2016 | Shangri-la Hotel, Singapore
OUR UNIQUE FORMAT
The Bioinformatics Roundtable Discussions Strategy Meeting is free to attend for qualified end-users. These include Senior Executives of Biomedical Informatics, Scientific Computing and Digital Health (from medium to large Pharma, Biopharma and Biotech players) who aim to accelerate discovery, translational, clinical, CMC, and regulatory programs across the R&D pipeline, as well as thought leaders from Academia and regulatory authorities.
Thought leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
– R&D IT, Computational Biology/Sciences, Cloud Computing, Next-Gen Sequencing informatics, Clinical Research and Translational Informatics, Clinical Genomics, Data & Storage Management, Data Computing, Data Visualization & Exploration.
Steve RozenDirector & Professor
Duke-NUS Graduate Medical School of Singapore
Lawrence WeeChief Data Scientist
Sebastian Maurer-StrohProgramme Director Human Infectious Diseases
Zheng Jye LingAssistant Director
National University Health System
Shyam PrabhakarAssociate Director of Integrative Genomics
Genome Institute of Singapore
Asif M. KhanDean
Henry YangCancer Science Institute
Head of Bioinformatics Core
Human Longevity Inc.
James WeatherallExecutive Director & Head, Advanced Data Analytics
Bryn RobertsGlobal Head of Operations and Informatics, Pharmaceutical Research & Early Development
Quan YangGlobal Lead and Director, Biology Information Systems
Hongmei HuangHead of Informatics, Development Sciences
WHAT TO EXPECT
Interactive Roundtable Discussions
Attendees can proactively share and ask questions to their peers about the success of their work in an informal setting.
Director level one-to-one meetings
We provide opportunities to engage with one another in our strategy meeting in a series of pre-arranged business meetings by interacting face to face.
Tailor-fit and Personalized Agenda
Being able to experience different sessions is what makes our event unique that’s why our attendees can personalize and select sessions they want to participate in.
Several networking opportunities are in store for attendees to connect and build new relationships with their peers through luncheons, cocktails and informal introductions.
Thank you for reaching Proventa International
***The information you provided in this website is confidential and the company will strictly forbidden to share any part of these information with any third party without a written consent of the sender.
Our unique strategy meeting platform ensures that delegates can network with peers and benchmark their challenges whilst meeting a select number of supplier organizations that are currently at the forefront of innovation. This in turns helps them to save time and money associated in sourcing the best suppliers to procure solutions in an environment, which is 100% conducive to doing business.
If you are an exciting start-up trying to get your innovation in front global heads from the leading Pharmaceutical companies, or a mature market-leading conglomerate with legacy solutions trying to stay one step ahead of the competition – we are here to help!
WHAT PEOPLE SAY
BIOINFORMATICS Strategy Meeting APAC 2016,
Chief Information Officer
Its nice because they basically allowed people to engaged to discussions and questions. Academic and industry is very nice and informative
Ivan John Clement
Data Scientist - R&D
Its good because you really get the people to talk. They are willing to share their knowledge, the juniors are very eager to learn.
Manager Quality Assurance
The format is the beginning of breakthrough and integration, the level of delegates is very good and excellent, they learn a lot.
Founder & President
The kind of interaction is very interactive
Director & Professor
Because of diversity we really districts the points and all. People are very diversity and thoughtful in a round table.
22 Orange Grove Rd, Singapore 258350
+65 6737 3644
OUR MEDIA PARTNERS
Executive Director & Head, Advanced Data Analytics
Global Head of Operations and Informatics, Pharmaceutical Research & Early Development
Bryn gained his BSc and PhD in pharmacology from the University of Bristol, UK. Following post-doctoral work in neuropharmacology, he joined Organon as Senior Scientist in 1996. A number of roles followed with Zeneca and AstraZeneca, including team and project leader roles in high throughput screening and research informatics. In 2004 he became head of Discovery Informatics at the AstraZeneca sites in Cheshire, UK.
Bryn joined Roche in Basel in 2006, and his role as Global Head of Informatics was expanded in 2014 to Global Head of Operations for Pharma Research and Early Development. He is also the Centre Head for the Roche Innovation Centre Basel.
Beyond Roche, Bryn is a Visiting Fellow at the University of Oxford, where he is a member, and former chairman, of the scientific management committee for the Systems Approaches to Biomedical Sciences Centre for Doctoral Training. He is a member of the Pistoia Alliance board of directors, and was recognised in Fierce Biotech IT’s Top 10 Biotech Techies 2013.
Global Lead and Director, Biology Information Systems
Head of Informatics, Development Sciences
Hongmei joined Genentech in June 2017, and is responsible for the strategic leadership of Development Sciences efforts around informatics systems, data lifecycle management, data standards, analytics infrastructure, and ongoing data operations.
Hongmei is an accomplished Informatics leader with more than 20 years experience in the Pharmaceutical/Biotech Industry. Hongmei received her PhD in BioOrganic Chemistry from The Scripps Research Institute. She started her career as a Research Investigator at Bristol-Myers Squibb, and transitioned into Informatics over the course of her career. Prior to joining Genentech, Hongmei was responsible for strategy formulation, , and delivery of informatics and IT portfolios in partnership with R&D functions globally in various companies including Novartis and Assembly Biosciences.
Director & Professor, Duke-NUS Graduate Medical School of Singapore
Steve Rozen has made major contributions in the areas of bioinformatics, human genetics & cancer genomics. He created and maintains the widely-used Primer3 software for PCR primer design. He worked extensively on identifying mutations in human Y chromosomes and their clinical consequences, as reported in multiple publications in Nature Genetics and Nature. Rozen founded and directs the Duke-NUS Centre for Computational Biology. The Centre's faculty have published > 140 scientific papers since 2011 and the Centre offers a PhD program in bioinformatics. Rozen's own laboratory focuses on bioinformatics and cancer genomics, and is part of a team-science effort in cancer genomics that has led to multiple papers, including 5 in Nature Genetics.
Chief Data Scientist, Zuellig Pharma
Dr. Lawrence Wee is currently the Chief Data Scientist at Zuellig Pharma. He has extensive experience in the research, innovation and commercialization of analytics across bioinformatics and healthcare domains. He has previously taken on the role of head of Biomedical and Healthcare Analytics at the Institute for Infocomm Research and President of the Association for Medical and Bioinformatics Singapore.
Programme Director Human Infectious Diseases, Bioinformatics Institute
Coming from Austria, via Belgium to Singapore, Dr. Sebastian Maurer-Stroh leads a group of experts in computational sequence and structure analysis as senior principal investigator in the A*STAR Bioinformatics Institute (BII) since 2007. With more than 110 publications in the field, he is known for developing the currently most comprehensive influenza mutation analysis tool, the FluSurver, which is used by researchers, National Influenza Centres, WHO Collaborating Centres and the GISAID initiative. He is also heading an infectious disease programme that has been involved in local high profile outbreak analyses such as the Hep C cluster in SGH or the first Zika genomes from the Singapore outbreak.
Zheng Jye Ling
Assistant Director, National University Health System
Dr Ling Zheng Jye is an ILTC physician who works on improving NUH’s electronic medical records systems to make life better. Combining public health perspectives with user experience design, he enjoys helping the amazing people in Singapore healthcare with tailoring products to fit local workflows. He is currently working on effective use of hospital data to improve outcomes and efficiency. Work is a real joy, because he gets to help his friends deliver care more effectively and happily!
Asif M. Khan
Dean, Perdana University
Dr. Khan is currently appointed as the Director of the Perdana University Centre for Bioinformatics (PU-CBi), Malaysia, Acting Dean of the Perdana University School of Data Sciences (PU-SDS), and Visiting Scientist for the Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine (JHUSOM), USA. His research interests are in the area of biological data warehousing and applications of bioinformatics to the study of immune responses, vaccines, venom toxins, drug design, and disease biomarkers. He has authored/co-authored more than 40 international, peer-reviewed research and review articles in various international journals, books and conferences, and presented his work at numerous international conferences. He was involved in the of several novel bioinformatics methodologies, tools, and specialized databases, and currently has three patent applications granted. His teaching experiences (2006-2016) have been in bioinformatics, imparting to undergraduate/postgraduate students at the National University of Singapore and to medical and bioinformatics students at Perdana University; and has assisted in the supervision of research projects of more than 50 students. His publications include three peer-reviewed journal articles and two book chapters on bioinformatics education. He has led the curriculum of a unique Postgraduate Diploma in Bioinformatics programme and an MSc (Bioinformatics) programme (by Research at Perdana University, with the aim of providing students the foundation necessary to manage and mine the wealth of available biological data for knowledge discovery. He is currently an ExCo member and Vice President (Corporate) of the Asia-Pacific Bioinformatics Network (APBioNET); he is also a Honorary Director of APBioNET Limited (LTD). His services to the scientific community include as a reviewer for several journals, conferences, and funding agencies, and has donned various important roles in the organization of several local and international bioinformatics conferences, meetings and workshops.
CIO, Human Longevity Inc.
Chief Information Officer, Human Longevity, Inc. and Managing Director, Human Longevity Singapore.
Dr. Yaron Turpaz is a proven research and IT leader in the biotech and pharma space with hands on experience using computational and informatics platforms for drug discovery and applications. In his role as CIO at Human Longevity, Inc. (HLI), Dr Turpaz is responsible for building and growing the company’s genomic and phenotypic KnowledgebaseTM business, and leads all bioinformatics/informatics and software engineering efforts. Dr Turpaz is expanding informatics program at HLI’s California facility, as well as building a computing and informatics program and facility in Singapore, with a focus on collaborations with the pharmaceutical and healthcare industry. Prior to joining HLI, he worked at AstraZeneca as Vice President, R&D IT; At Eli Lilly Singapore Centre for Drug Discovery as Director of Integrative Computational Sciences, and at Affymetrix, Inc. as Senior Manager, Bioinformatics and Algorithms Development. Dr Turpaz has BS in Biology from Tel Aviv University, a Ph.D. in Bioengineering from the University of Illinois and an MBA from the University of Chicago, Booth School of Business. He also held an adjunct assistant professor at the Centre for Quantitative Medicine of Duke-National University of Singapore, Graduate Medical School in Singapore.
Associate Director of Integrative Genomics, Genome Institute of Singapore
Shyam Prabhakar obtained a B.Tech in Electronics Engineering from IIT-Madras and a PhD in Applied Physics from Stanford University. He was the sole recipient of the 2001 American Physical Society thesis award in Beam Physics. As a postdoctoral fellow at the Lawrence Berkeley National Laboratory, he led seminal studies of human evolution before joining the Genome Institute of Singapore, where his group brings data analytics and cutting-edge omics technologies to precision medicine. He is now Associate Director of Integrative Genomics, Head of the Single Cell Omics Centre and co-leader of the A*STAR centre for Big Data and Integrative Genomics (c-BIG).
Cancer Science Institute, Head of Bioinformatics Core
Dr Henry Yang is currently a research associate professor at Cancer Science Institute of Singapore (CSI), National University of Singapore, and heads the Bioinformatics Core at the institute. His main research focuses are on 1) of effective analysis pipelines for large-scale genomic data; 2) integrative analysis of expression, splicing, and RNA editing from the transcriptomic data, as well as mutations and epigenetic modifications from genomic and epigenomic data; 3) identification of novel biomarkers and drug targets based on integrative analysis of genomic/transcriptomic data with clinical data; and 4) integrative analysis of large-scale public data sets such as TCGA, 1000Genome, dbGAP and GEO. Prior to joining CSI 4+ years ago, Dr Yang worked as a principal investigator in the area of large-scale transcriptome analysis and integrative analysis for discovery of novel targets/biomarkers and regulatory mechanisms at two A-STAR institutes (Bioinformatics Institute and Singapore Immunology Network) for several years.